Transforming growth factor-β (TGF-β) is an inducer of type I collagen, and uncontrolled collagen production leads to tissue scarring and organ failure. Here we hypothesize that uncovering a molecular mechanism that enables us to switch off type I collagen may prove beneficial in treating fibrosis. For the first time, to our knowledge, we provide evidence that CUX1 acts as a negative regulator of TGF-β and potent inhibitor of type I collagen transcription. We show that CUX1, a CCAAT displaceme...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
High doses of TGF-β potently suppress type I collagen via the transcription factor CUX1.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record